Shengmai San (ingredients include ginseng, Ophiopogon japonicus, and Schisandra chinensis): clinical trials recruiting now

Fewer than 3 recruiting trials found.

Phase breakdown

Conditions being studied

Recruiting trials involving Shengmai San (ingredients include ginseng, Ophiopogon japonicus, and Schisandra chinensis)

• The Use of Shengmai San to Prevent Anthracycline Sequential Trastuzumab Therapy Related Cardiac Toxicity
  NCT06214195 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many recruiting trials involve Shengmai San (ingredients include ginseng, Ophiopogon japonicus, and Schisandra chinensis)?

1 recruiting trial across 2 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.